TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Therapeuticsmd, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:04.500 for the Therapeutics MD Second Quarter 2022 00:00:04.670 -- 00:00:09.672 Financial Results Conference Call. Following prepared remarks from the company, we 00:00:09.672 -- 00:00:14.313 will open the call for questions. I would now like to turn the call over to Investor 00:00:14.313 -- 00:00:17.854 Relations for Therapeutics MD, Lisa Wilson. 00:00:17.854 -- 00:00:18.474 Lisa? 00:00:18.474 -- 00:00:23.656 Thank you, Operator. Good morning, everyone, and thank you for joining today to discuss 00:00:23.656 -- 00:00:27.793 our second quarter financial results and business updates. 00:00:27.793 -- 00:00:29.875 This morning, TherapeuticsMD 00:00:29.875 -- 00:00:33.777 issued a press release announcing its second quarter 2022 00:00:33.777 -- 00:00:35.739 financial results. 00:00:35.739 -- 00:00:39.341 The press release and accompanying presentation 00:00:39.341 -- 00:00:43.685 are available on the company's website, TherapeuticsMD, 00:00:43.685 -- 00:00:46.767 in the Investors and Media section. 00:00:46.767 -- 00:00:49.749 On today's call from TherapeuticsMD 00:00:49.749 -- 00:00:54.873 are Chief Executive Officer Hugh O'Dowd, Interim Chief Financial 00:00:54.873 -- 00:01:00.633 Officer Michael Donegan, and Chief Commercial Officer Mark Glickman. 00:01:00.633 -- 00:01:04.736 I would like to remind everyone that certain statements made during this conference call 00:01:04.736 -- 00:01:09.179 may be forward-looking statements. Such forward-looking statements are based upon current 00:01:09.179 -- 00:01:14.263 expectations and there can be no assurance that the results contemplated in these statements 00:01:14.263 -- 00:01:16.104 will be realized. 00:01:16.104 -- 00:01:21.188 Actual results may differ materially from such statements due to a...